University of Chicago Medicine researchers have built a model system that
uses multiple cell types from patients to rapidly test compounds that could block the early steps in ovarian cancer metastasis.
February 10, 2015 New screening tool could speed development of ovarian cancer drugs University of Chicago Medicine researchers have built a model system that
uses multiple cell types from patients to rapidly test compounds that could block the early steps in ovarian cancer metastasis.
Not exact matches
To build nationwide 5G, they either have to kick current customers off LTE, which would take years, or
use a
type of spectrum (millimeter wave) that can only carry a signal 2,000 feet from a
cell site — versus
multiple miles for other spectrum — making it nearly impossible for either of them to create a truly nationwide 5G network quickly.
Breech Twins and higher order
multiples Previous CS Pre-Eclampsia Placenta praevia Cervical incompetence Previous late stillbirth Previous premature birth Grand multiparty Age under 18 Age over 35 Smoking Drug
use Severe mental health issue Epilepsy
Type 1 diabetes
Type 2 diabetes Gestational diabetes Asthma GBS positive Abnormal antibodies Transplant recipient Congenital heart disease Known foetal abnormality Immunosuppressive medication MS Physical disability Intellectual disability Hypothyroidism Hyperthyroidism Previous shoulder dystocia Previous 3rd or 4th degree tear Sickle
Cell anaemia BMI under 18 or over 35 at conception Previous massive PPH APH in current pregnancy HIV / AIDS Hepatitis B or C Active TB IUGR Oligohydramnios Polyhydramnios Child previously removed from custody because of abuse Uterine abnormalities such as uterine septum or double uterus Previous uterine surgery for fibroids Chronic renal problems Hypertension Auto immune condition Previous stroke or blod clot Cancer Domestic violence or abusive home Prisoners Homeless women
(borrowed from Dr Kitty) Breech Twins and higher order
multiples Previous CS Pre-Eclampsia Placenta praevia Cervical incompetence Previous late stillbirth Previous premature birth Grand multiparty Age under 18 Age over 35 Smoking Drug
use Severe mental health issue Epilepsy
Type 1 diabetes
Type 2 diabetes Gestational diabetes Asthma GBS positive Abnormal antibodies Transplant recipient Congenital heart disease Known foetal abnormality Immunosuppressive medication MS Physical disability Intellectual disability Hypothyroidism Hyperthyroidism Previous shoulder dystocia Previous 3rd or 4th degree tear Sickle
Cell anaemia BMI under 18 or over 35 at conception Previous massive PPH APH in current pregnancy HIV / AIDS Hepatitis B or C Active TB IUGR Oligohydramnios Polyhydramnios Child previously removed from custody because of abuse Uterine abnormalities such as uterine septum or double uterus Previous uterine surgery for fibroids Chronic renal problems Hypertension Auto immune condition Previous stroke or blod clot Cancer Domestic violence or abusive home Prisoners Homeless women
Whether investigating fat
cells, immunotherapy or
use of the CRISPR - Cas 9 gene - editing tool, which a federal panel recently approved for a select number of patients suffering from three
types of cancers, including
multiple myeloma, approaches beyond attacking cancer
cells are needed in the fight against many cancers.
When you're
using certain tissue
types that can't replicate
multiple times outside of the body — liver and nerve
cells, for example — «that's where stem
cells are most relevant.»
Researchers at MIT have now shown that they can
use a new
type of measurement to predict how drugs will affect cancer
cells taken from
multiple - myeloma patients.
Using different
types of perovskites across
multiple layers could allow solar
cells to more effectively absorb a broader range of photons.
Theoretically, such stem
cells can form any of the body's
cell types and could be
used in new treatments for Parkinson's disease, diabetes,
multiple sclerosis, cardiac disease, and spinal cord injuries.
Human mesenchymal stem
cells (hMSCs) are currently the most common adult stem
cell type used for
cell therapy applications due to their regenerative properties and ability to differentiate into
multiple cell lineages (adipocyte, chondro ¬ cyte, and osteocyte).
Several
types of targeted therapy may be
used to treat
multiple myeloma and other plasma
cell neoplasms.
We compared the
cell - fractions of pre - and post-mortem samples globally
using the Anderson — Darling test53 and by
cell -
type obtaining a p - value
using the two - sided Wilcoxon Rank - Sum test54, adjusted to
multiple - testing by Benjamini — Hochberg method44.
«The best case scenario is that from this one very accessible and highly proliferative source of stem
cells, we will be able to obtain
multiple different
cell types that can be
used for a broad range of applications in regenerative medicine,» he said.
Using red blood
cells modified to carry disease - specific antigens, a team of scientists from Whitehead Institute and Boston Children's Hospital have prevented and alleviated two autoimmune diseases —
multiple sclerosis (MS) and
type 1 diabetes — in early stage mouse models.